133 related articles for article (PubMed ID: 38228398)
1. Local injection of micro-dose guselkumab for acrodermatitis continua of Hallopeau after failure of systemic ixekizumab treatment.
Wang Y; Zhou C; Hou Y; Diao Z; Chen D; Yin Z
Int J Dermatol; 2024 Apr; 63(4):547-548. PubMed ID: 38228398
[No Abstract] [Full Text] [Related]
2. A case of acrodermatitis continua of Hallopeau evolving into generalized pustular psoriasis successfully treated with guselkumab.
Yamamoto H; Kamiya K; Okada H; Maekawa T; Komine M; Ohtsuki M
Int J Dermatol; 2023 Feb; 62(2):269-270. PubMed ID: 35187654
[No Abstract] [Full Text] [Related]
3. Acrodermatitis continua of Hallopeau successfully treated with ixekizumab: A case report.
Battista T; Guerrasio G; De Fata Salvatores G; Peduto T; Fabbrocini G; Di Guida A
Dermatol Ther; 2022 May; 35(5):e15383. PubMed ID: 35174591
[No Abstract] [Full Text] [Related]
4. A case of acrodermatitis continua of Hallopeau successfully treated with guselkumab.
Buononato D; Licata G; Gambardella A; De Rosa A; Calabrese G; Argenziano G
Dermatol Ther; 2022 Jul; 35(7):e15514. PubMed ID: 35420733
[No Abstract] [Full Text] [Related]
5. Treatment of acrodermatitis continua of hallopeau with ixekizumab.
Miller AC; Holland TE; Cohen DJ
J Dermatolog Treat; 2021 Feb; 32(1):117-119. PubMed ID: 31184530
[TBL] [Abstract][Full Text] [Related]
6. The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review.
Maliyar K; Crowley EL; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
J Cutan Med Surg; 2019; 23(4):428-435. PubMed ID: 30938189
[TBL] [Abstract][Full Text] [Related]
7. Brodalumab in the treatment of recalcitrant acrodermatitis continua of Hallopeau.
Bardazzi F; Di Altobrando A; Lacava R
Dermatol Ther; 2020 Nov; 33(6):e14301. PubMed ID: 32920959
[No Abstract] [Full Text] [Related]
8. Spesolimab Response in a Girl With Acrodermatitis Continua of Hallopeau.
Wang Y; Zhang L; Zheng J; Li X; Chen L
JAMA Dermatol; 2024 Apr; 160(4):476-477. PubMed ID: 38416455
[TBL] [Abstract][Full Text] [Related]
9. A case of pediatric acrodermatitis continua of Hallopeau successfully treated with adalimumab biosimilar.
Megna M; Fabbrocini G; Costa C; Ferrillo M
Dermatol Ther; 2020 May; 33(3):e13327. PubMed ID: 32220123
[No Abstract] [Full Text] [Related]
10. Treatment of acrodermatitis continua of Hallopeau with adalimumab.
Ryan C; Collins P; Kirby B; Rogers S
Br J Dermatol; 2009 Jan; 160(1):203-5. PubMed ID: 18945314
[No Abstract] [Full Text] [Related]
11. Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.
Galluzzo M; D'Adamio S; Teoli M; Bianchi L; Talamonti M
Dermatol Ther; 2019 May; 32(3):e12899. PubMed ID: 30969010
[TBL] [Abstract][Full Text] [Related]
12. Acrodermatitis continua of Hallopeau: treatment with etretinate and review of relapsing pustular eruptions of the hands and feet.
Pearson LH; Allen BS; Smith JG
J Am Acad Dermatol; 1984 Oct; 11(4 Pt 2):755-62. PubMed ID: 6491002
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of adalimumab for the treatment of refractory paediatric acrodermatitis continua of hallopeau.
Dini V; Barbanera S; Romanelli M
Acta Derm Venereol; 2013 Sep; 93(5):588-9. PubMed ID: 23407925
[No Abstract] [Full Text] [Related]
14. Local injection of micro-dose guselkumab for palmoplantar pustulosis after partial failure of systemic ixekizumab treatment.
Zhou C; Chen D; Diao Z; Wang Y; Hou Y; Yin Z
Australas J Dermatol; 2024 May; 65(3):e75-e76. PubMed ID: 38439213
[TBL] [Abstract][Full Text] [Related]
15. Acrodermatitis continua of Hallopeau successfully treated with secukinumab.
Balestri R; Rech G; Tasin L; Rizzoli L; Girardelli CR
J Dermatolog Treat; 2018; 29(sup1):3-5. PubMed ID: 30246571
[TBL] [Abstract][Full Text] [Related]
16. Acrodermatitis continua of Hallopeau: was it an outcome of a surgical trauma or initially misdiagnosed as onychomycosis?
Sahin MT; Oztürkcan S; Türel A; Kandiloğlu AR
J Eur Acad Dermatol Venereol; 2003 Mar; 17(2):236-8. PubMed ID: 12705767
[No Abstract] [Full Text] [Related]
17. An infant with acrodermatitis continua of Hallopeau: successful treatment with thalidomide and UVB therapy.
Kiszewski AE; De Villa D; Scheibel I; Ricachnevsky N
Pediatr Dermatol; 2009; 26(1):105-6. PubMed ID: 19250426
[TBL] [Abstract][Full Text] [Related]
18. Pustular psoriasis and acrodermatitis continua (Hallopeau) need high doses of systemic ciclosporin A.
Korstanje MJ; Bessems PJ; Hulsmans RF; van de Staak WJ
Dermatologica; 1989; 179(2):90-1. PubMed ID: 2792497
[No Abstract] [Full Text] [Related]
19. Adalimumab treatment for acrodermatitis continua of Hallopeau: three cases refractory to IL-17 inhibition.
Zhang Z; Wu X; Han C; Chen M; Liu Y
J Dtsch Dermatol Ges; 2023 Jul; 21(7):785-787. PubMed ID: 37186059
[No Abstract] [Full Text] [Related]
20. Etanercept for pediatric acrodermatitis continua of Hallopeau: A case report and literature review.
Ruggiero A; Patruno C; Napolitano M; Megna M; Gisonni P; Cirillo T; Fabbrocini G
Dermatol Ther; 2020 Nov; 33(6):e14046. PubMed ID: 32700773
[No Abstract] [Full Text] [Related]
[Next] [New Search]
